Regulatory tracker: Ipsen picks up EU approvals for rare disease meds Kayfanda, Iqviro
Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. UPDATED: Monday, September 23 at …